Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli
Alessandro
A
Department of Internal Medicine, University of Pisa, School of Medicine, Via Roma 67, Pisa, Italy. a.antonelli@med.unipi.it
Ferrari
Silvia Martina
SM
Fallahi
Poupak
P
Ghiri
Emiliano
E
Crescioli
Clara
C
Romagnani
Paola
P
Vitti
Paolo
P
Serio
Mario
M
Ferrannini
Ele
E
D054357:Chemokine CXCL10 / Q000378:metabolism*; D054370:Chemokine CXCL9 / Q000378:metabolism*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D016899:Interferon-beta / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D007372:Interferons / Q000494:pharmacology*; D047495:PPAR gamma / Q000819:agonists*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology*; D013961:Thyroid Gland / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*
C114753:CXCL10 protein, human; C080810:CXCL9 protein, human; D054357:Chemokine CXCL10; D054370:Chemokine CXCL9; D016898:Interferon-alpha; D047495:PPAR gamma; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D016899:Interferon-beta; D007371:Interferon-gamma; D007372:Interferons